EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AXIN2 promotes degradation of AXIN1 through tankyrase in colorectal cancer cells

Olivia Schmidt, Martina Brückner, Dominic B Bernkopf iD

The FEBS Journal · 2025-03 · 292 (5) · 1019-1033

DOI: 10.1111/febs.17226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, online erschienen am 18.07.2024. Verfasst von Olivia Schmidt und 2 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Medicine II, Nikolaus-Fiebiger-Center, Friedrich-Alexander University Erlangen-Nürnberg, Germany. Hauptthemen laut MEDLINE: Axin Protein, Tankyrases, Colorectal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wilhelm Sander-Stiftung, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AXIN1 and AXIN2 are homologous proteins that inhibit the Wnt/β‐catenin signaling pathway, which is frequently hyperactive in colorectal cancer. Stabilization of AXIN1 and AXIN2 by inhibiting their degradation through tankyrase (TNKS) allows the attenuation of Wnt signaling in cancer, attracting interest for potential targeted therapy. Here, we found that knockout or knockdown of AXIN2 in colorectal cancer cells increased the protein stability of AXIN1. The increase in AXIN1 overcompensated for the loss of AXIN2 with respect to protein levels; however, functionally it did not because loss of AXIN2 activated the pathway. Moreover, AXIN2 was highly essential in the context of TNKS inhibition because TNKS‐targeting small‐molecule inhibitors completely failed to inhibit Wnt signaling and to stabilize AXIN1 in AXIN2 knockout cells. The increased AXIN1 protein stability and the impaired stabilization by TNKS inhibitors indicated disrupted TNKS‐AXIN1 regulation in AXIN2 knockout cells. Concordantly, mechanistic studies revealed that co‐expression of AXIN2 recruited TNKS to AXIN1 and stimulated TNKS‐mediated degradation of transiently expressed AXIN1 wild‐type and AXIN1 mutants with impaired TNKS binding. Taken together, our data suggest that AXIN2 promotes degradation of AXIN1 through TNKS in colorectal cancer cells by directly linking the two proteins, and these findings may be relevant for TNKS inhibition‐based colorectal cancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Axin ProteinTankyrasesColorectal NeoplasmsHumansWnt Signaling PathwayProteolysisCell Line, TumorProtein StabilityGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

AXIN1AXIN2TNKSWnt pathwaycolorectal cancer

Substanzen

Axin ProteinTankyrasesAXIN1 protein, humanAXIN2 protein, humanTNKS protein, human

Autor:innen und Institutionen

  • Experimental Medicine II, Nikolaus-Fiebiger-Center, Friedrich-Alexander University Erlangen-Nürnberg, Germany.

ORCID-Profile: Dominic B Bernkopf

Förderung

  • Wilhelm Sander-Stiftung
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Schmidt, O., Brückner, M., & Bernkopf, D. B. (2025). AXIN2 promotes degradation of AXIN1 through tankyrase in colorectal cancer cells. The FEBS Journal, 292(5), 1019-1033. https://doi.org/10.1111/febs.17226

Vancouver

Schmidt O, Brückner M, Bernkopf DB. AXIN2 promotes degradation of AXIN1 through tankyrase in colorectal cancer cells. The FEBS Journal. 2025;292(5):1019-1033. doi:10.1111/febs.17226

BibTeX
@article{Schmidt2025,
  author = {Schmidt, Olivia and Brückner, Martina and Bernkopf, Dominic B},
  title = {AXIN2 promotes degradation of AXIN1 through tankyrase in colorectal cancer cells},
  journal = {The FEBS Journal},
  year = {2025},
  volume = {292},
  number = {5},
  pages = {1019--1033},
  doi = {10.1111/febs.17226}
}
Kostenlos starten →